103 related articles for article (PubMed ID: 10102393)
41. Regression of metastatic liver tumors in rats treated with angiogenesis inhibitor TNP-470: occurrence of apoptosis and necrosis.
Ahmed MH; Arai T; Konno H; Nahar L; Tanaka T; Izumiyama N; Takubo K; Nakamura S; Baba S
Jpn J Cancer Res; 1997 Oct; 88(10):977-81. PubMed ID: 9414660
[TBL] [Abstract][Full Text] [Related]
42. Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models.
Herbst RS; Takeuchi H; Teicher BA
Cancer Chemother Pharmacol; 1998; 41(6):497-504. PubMed ID: 9554595
[TBL] [Abstract][Full Text] [Related]
43. Angiogenesis inhibition by minocycline.
Tamargo RJ; Bok RA; Brem H
Cancer Res; 1991 Jan; 51(2):672-5. PubMed ID: 1702361
[TBL] [Abstract][Full Text] [Related]
44. Angiogenesis inhibitor TNP-470 augments the effect of repeated arterial ischemia on growth but does not affect take in a rat liver tumor model.
Möller PH; Ivarsson K; Roos G; Radnell M; Persson B; Tranberg KG; Stenram U
Anticancer Res; 1997; 17(4A):2401-6. PubMed ID: 9252654
[TBL] [Abstract][Full Text] [Related]
45. TNP-470 inhibits collateralization to complement the anti-tumour effect of hepatic artery ligation.
Mugitani T; Taniguchi H; Takada A; Yamaguchi A; Masuyama M; Hoshima M; Takahashi T
Br J Cancer; 1998 Feb; 77(4):638-42. PubMed ID: 9484823
[TBL] [Abstract][Full Text] [Related]
46. [Experimental study of the effect of angiogenesis inhibitor TNP-470 on the growth and metastasis of gastric cancer in vivo].
Liu B; Lin Y; Yin H
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):34-6. PubMed ID: 10921053
[TBL] [Abstract][Full Text] [Related]
47. Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470.
Devineni D; Klein-Szanto A; Gallo JM
Cancer Res; 1996 May; 56(9):1983-7. PubMed ID: 8616836
[TBL] [Abstract][Full Text] [Related]
48. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo.
Yanase T; Tamura M; Fujita K; Kodama S; Tanaka K
Cancer Res; 1993 Jun; 53(11):2566-70. PubMed ID: 7684319
[TBL] [Abstract][Full Text] [Related]
49. [An experimental study of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of Lewis lung carcinoma].
Xia J; Yang B
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):333-5. PubMed ID: 10920909
[TBL] [Abstract][Full Text] [Related]
50. Inhibitory effect of TNP-470, a new anti-angiogenic agent, on the estrogen induced rat pituitary tumors.
Takechi A; Uozumi T; Kawamoto K; Ito A; Kurisu K; Sudo K
Anticancer Res; 1994; 14(1A):157-62. PubMed ID: 7513141
[TBL] [Abstract][Full Text] [Related]
51. Experimental studies of the antitumor effect of TNP-470 on malignant brain tumors. Antitumor effect of TNP-470 on a human medulloblastoma xenograft line.
Isobe N; Uozumi T; Kurisu K; Kawamoto K
Neuropediatrics; 1996 Jun; 27(3):136-42. PubMed ID: 8837073
[TBL] [Abstract][Full Text] [Related]
52. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents.
Teicher BA; Holden SA; Ara G; Sotomayor EA; Huang ZD; Chen YN; Brem H
Int J Cancer; 1994 Jun; 57(6):920-5. PubMed ID: 7515861
[TBL] [Abstract][Full Text] [Related]
53. Importance of timing and length of administration of angiogenesis inhibitor TNP-470 in the treatment of K12/TRb colorectal hepatic metastases in BD-IX rats.
Watson JC; Sutanto-Ward E; Osaku M; Weinstein JK; Babb JS; Sigurdson ER
Surgery; 1999 Aug; 126(2):358-63. PubMed ID: 10455906
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic potential of the anti-angiogenesis drug TNP-470.
Gervaz P; Fontolliet C
Int J Exp Pathol; 1998 Dec; 79(6):359-62. PubMed ID: 10319017
[TBL] [Abstract][Full Text] [Related]
55. Complete remission of Bomirski Ab amelanotic melanoma in hamsters treated with the angiogenesis inhibitor TNP-470.
Myśliwski A; Koszałka P; Bigda J; Szmit E
Neoplasma; 2002; 49(5):319-22. PubMed ID: 12458330
[TBL] [Abstract][Full Text] [Related]
56. Optimizing the dosing schedule of TNP-470 [O-(chloroacetyl-carbamoyl) fumagillol] enhances its antitumor and antiangiogenic efficacies.
Koyanagi S; Nakagawa H; Kuramoto Y; Ohdo S; Soeda S; Shimeno H
J Pharmacol Exp Ther; 2003 Feb; 304(2):669-74. PubMed ID: 12538820
[TBL] [Abstract][Full Text] [Related]
57. The pharmacokinetics of TNP-470, a new angiogenesis inhibitor.
Figg WD; Pluda JM; Lush RM; Saville MW; Wyvill K; Reed E; Yarchoan R
Pharmacotherapy; 1997; 17(1):91-7. PubMed ID: 9017768
[TBL] [Abstract][Full Text] [Related]
58. Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470.
Kudelka AP; Verschraegen CF; Loyer E
N Engl J Med; 1998 Apr; 338(14):991-2. PubMed ID: 9527612
[No Abstract] [Full Text] [Related]
59. [A comparison of three methods in establishing transplanted model of VX2 tongue carcinoma in rabbits].
Tian J; Liao GQ; Liu HC; Li CZ; Li Q; Wang JX; Du RC; Zhang TH
Hua Xi Kou Qiang Yi Xue Za Zhi; 2009 Jun; 27(3):326-9. PubMed ID: 19637489
[TBL] [Abstract][Full Text] [Related]
60. Angiogenesis inhibitor TNP-470 prevents implanted liver metastases after partial hepatectomy in an experimental model without impairing wound healing.
Tanaka H; Taniguchi H; Mugitani T; Koishi Y; Masuyama M; Koyama H; Hoshima M; Takahashi T
Br J Surg; 1996 Oct; 83(10):1444-7. PubMed ID: 8944468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
